Citigroup Adjusts Beam Therapeutics Price Target to $56 From $60, Maintains Buy Rating -August 09, 2023 at 08:06 am EDT | MarketScreener
Beam Therapeutics Stock: An Upgraded View (NASDAQ:BEAM) | Seeking Alpha
Beam Therapeutics Stock: A Leader in Gene Editing Tech? - Nanalyze
BEAM Stock: Should Be Part Of Every Investor's Portfolio | Seeking Alpha
Beam Therapeutics Announces Pricing of Initial Public Offering | Business Wire
Beam Therapeutics Inc Share Price Today: Live BEAM Stock Quote & Charts | 5paisa
Beam Therapeutics Stock Forecast: down to 0.000000011 USD? - BEAM Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
BEAM Stock Price Forecast. Should You Buy BEAM?
Beam Therapeutics Stock Forecast: down to 0.000000011 USD? - BEAM Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
BEAM Stock Price and Chart — NASDAQ:BEAM — TradingView
Beam Therapeutics Stock Forecast: down to 0.000000011 USD? - BEAM Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Where Beam Therapeutics Stands With Analysts | Markets Insider
BEAM Intrinsic Valuation and Fundamental Analysis - Beam Therapeutics Inc - Alpha Spread
Beam Therapeutics Partners with Pfizer, Leading the Base Editing Revolution - YouTube
BEAM: Beam Therapeutics Inc Stock Price Quote - NASDAQ GS - Bloomberg
Beam Therapeutics: Awaiting Clinical Progress And Path Towards Profitability (BEAM) | Seeking Alpha
SEC Filing | Beam Therapeutics
2 Magnificent Growth Stocks to Buy On the Dip | The Motley Fool
Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare Conference -May 11, 2023 at 06:31 am EDT | MarketScreener
Beam Therapeutics Inc Shares Close the Day 12.5% Lower - Daily Wrap | Nasdaq
ARKK Holdings of Beam Therapeutics (BEAM) - Updated Daily
Beam Therapeutics Company Profile: Stock Performance & Earnings | PitchBook
Beam Therapeutics Stock: Getting More And More Interesting (NASDAQ:BEAM) | Seeking Alpha
Beam makes $120M bet that GuideTx's tech brings gene editing beyond the liver - MedCity News
Beam Therapeutics (BEAM) - Market capitalization
BEAM Stock Price and Chart — NASDAQ:BEAM — TradingView
